For Hire

INVESTOR NOTICE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB

Retrieved on: 
Tuesday, August 2, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Private Securities Litigation Reform Act, Identity theft, Company, The Wall Street Journal, Hindenburg, For Hire, History, Central District, FBI, China Biologic Products, Securities Exchange Act of 1934, Risk, U.S. Department of Justice Office of Legislative Affairs, List of life sciences, NASDAQ, Fraud, Cancer, News, CASE, Robbins Geller Rudman & Dowd LLP, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Science, G-Technology, SEC, Lawyer, Lists of schools in England, Justice, HBV, Hindenburg Research, Complaint, LLC, SRI, HIV, Coronavirus, Enron, Tobacco, Pharmaceutical industry, Enochian

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Monday, August 1, 2022
Seraph, LLP, Identity theft, Company, GLOBE, Court, For Hire, Hindenburg, Central District, Lists of action films, Hepatitis B virus, Person, China Biologic Products, Securities Exchange Act of 1934, HIV, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Fraud, Cancer, News, SEC Rule 10b-5, Ext, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Science, Defendant, G-Technology, Lists of schools in England, Complaint, District court, Justice, Hindenburg Research, LLC, SRI, Pomerantz, Coronavirus, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian and Weber and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, August 1, 2022
Seraph, Register, Identity theft, IPO, GLOBE, WEBR, For Hire, Hindenburg, NYSE, Hepatitis B virus, Registration statement, China Biologic Products, HIV, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Fraud, Cancer, News, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Company, Science, Defendant, G-Technology, Lists of schools in England, Justice, Hindenburg Research, Complaint, LLC, SRI, Coronavirus, Private investigator, Renewable energy, Pharmaceutical industry, Security (finance), Enochian, P.C

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • Additionally, Weber announced that Chris Scherzinger is departing from his roles as Chief Executive Officer and director of the Company.
  • For more information on the Weber class action go to: https://bespc.com/cases/WEBR
    About Bragar Eagel & Squire, P.C.

ENOCHIAN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Enochian Biosciences, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 28, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Identity theft, Court, For Hire, Hindenburg, Jeanne Eagels, Telephone, Central District, Hepatitis B virus, Person, China Biologic Products, HIV, Risk, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Fraud, Cancer, News, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Company, P.C, Science, Defendant, G-Technology, Lists of schools in England, District court, Justice, Hindenburg Research, LLC, SRI, Coronavirus, Private investigator, Renewable energy, Pharmaceutical industry, Enochian

Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

INVESTOR ALERT: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB

Retrieved on: 
Wednesday, July 27, 2022
Class Action Lawsuit, Professional Services, Legal, Seraph, Private Securities Litigation Reform Act, Identity theft, Company, Hindenburg, For Hire, History, China Biologic Products, Securities Exchange Act of 1934, Risk, List of life sciences, NASDAQ, Fraud, Cancer, News, Technology, Science, G-Technology, SEC, Lawyer, Lists of schools in England, Justice, HBV, Hindenburg Research, LLC, United States Department of Justice, SRI, HIV, Coronavirus, Enron, Tobacco, Pharmaceutical industry, Enochian

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.
  • An investors ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Enochian Biosciences class action lawsuit.

Pomerantz Law Firm Announces the Filing of a Class Action Against Enochian Biosciences Inc. and Certain Officers and Directors – ENOB

Retrieved on: 
Tuesday, July 26, 2022
Seraph, LLP, Identity theft, Company, GLOBE, Court, For Hire, Hindenburg, Central District, Lists of action films, Hepatitis B virus, Person, China Biologic Products, Securities Exchange Act of 1934, HIV, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Fraud, Cancer, News, SEC Rule 10b-5, Ext, Office of Inspector General, U.S. Department of Health and Human Services, Technology, Science, Defendant, G-Technology, Lists of schools in England, Complaint, District court, Justice, Hindenburg Research, LLC, SRI, Pomerantz, Coronavirus, Pharmaceutical industry, Private investigator, Renewable energy, Enochian

NEW YORK, July 26, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, July 26, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enochian Biosciences, Inc. - ENOB

Retrieved on: 
Thursday, June 23, 2022
GLOBE, Hindenburg, LLP, U.S. Department of Justice Office of Legislative Affairs, NASDAQ, Justice, Company, For Hire, Hindenburg Research, News, Office of Inspector General, U.S. Department of Health and Human Services, Pomerantz, Fraud, Identity theft, Renewable energy, Private investigator, Enochian

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ:ENOB).

Key Points: 
  • NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ:ENOB).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Enochian and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enochian Biosciences, Inc. - ENOB

Retrieved on: 
Tuesday, June 14, 2022
Hindenburg, News, For Hire, Office of Inspector General, U.S. Department of Health and Human Services, Fraud, GLOBE, Justice, U.S. Department of Justice Office of Legislative Affairs, Hindenburg Research, NASDAQ, Identity theft, LLP, Company, Pomerantz, Renewable energy, Private investigator, Enochian

NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ:ENOB).

Key Points: 
  • NEW YORK, June 13, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ:ENOB).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Enochian and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enochian Biosciences, Inc. - ENOB

Retrieved on: 
Sunday, June 5, 2022
Hindenburg, News, For Hire, Office of Inspector General, U.S. Department of Health and Human Services, Fraud, GLOBE, Justice, U.S. Department of Justice Office of Legislative Affairs, Hindenburg Research, NASDAQ, Identity theft, LLP, Company, Pomerantz, Renewable energy, Private investigator, Enochian

NEW YORK, June 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ:ENOB).

Key Points: 
  • NEW YORK, June 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enochian Biosciences, Inc. (Enochian or the Company) (NASDAQ:ENOB).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Enochian and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.